STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Company

Larimar Therapeutics, Inc.

Filed

May 31, 2024

Period of Report

February 16, 2024

Accession Number

0001062993-24-011568